Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 21, 2022

SELL
$177.01 - $223.45 $286,225 - $361,318
-1,617 Closed
0 $0
Q3 2021

Oct 22, 2021

SELL
$181.39 - $202.99 $181 - $202
-1 Reduced 0.06%
1,617 $293,000
Q2 2021

Jul 21, 2021

BUY
$187.49 - $221.1 $9,374 - $11,055
50 Added 3.19%
1,618 $326,000
Q1 2021

Apr 23, 2021

SELL
$207.02 - $241.31 $22,565 - $26,302
-109 Reduced 6.5%
1,568 $337,000
Q4 2020

Jan 26, 2021

BUY
$207.01 - $276.09 $145,114 - $193,539
701 Added 71.82%
1,677 $396,000
Q3 2020

Oct 30, 2020

BUY
$255.65 - $303.1 $249,514 - $295,825
976 New
976 $266,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Columbus Macro, LLC Portfolio

Follow Columbus Macro, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbus Macro, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Columbus Macro, LLC with notifications on news.